How should we value lives lost to cancer?

Journal of the National Cancer Institute

Volumn 100, Issue 24, 2008, Pages 1742-1743

  Ramsey, Scott D ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER MORTALITY; COLORECTAL CANCER; EDITORIAL; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; LUNG CANCER; PRIORITY JOURNAL; PRODUCTIVITY; PROSTATE CANCER; SOCIOECONOMICS;

BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COST OF ILLNESS; EFFICIENCY; FEMALE; FORECASTING; HEALTH CARE COSTS; HEALTH POLICY; HOME NURSING; HOUSEKEEPING; HUMANS; LIFE TABLES; LUNG NEOPLASMS; MALE; NEOPLASMS; PALLIATIVE CARE; PRIMARY PREVENTION; PROSTATIC NEOPLASMS; UNITED STATES; VALUE OF LIFE;

EID: 58049217467     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn434     Document Type: Editorial

References (12)

1. Mooney GH, ed. Economics, Medicine and Health Care. 2nd ed. Hemel Hempstead, UK: Harvester Wheatsheaf; 1992.
2. Yabroff KR, Bradley CJ, Mariotto AB, Brown ML, Feuer EJ. Estimates and projections of value of life lost from cancer deaths in the United States. J Natl Cancer Inst. 2008;100(24):1755-1762.
3. Bradley CJ, Yabroff KR, Dahman B, Feuer EJ, Mariotto A, Brown ML. Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst. 2008;100(24):1763-1770.
4. USA Today, Kaiser Family Foundation, and Harvard School of Public Health. National Survey of Households Affected by Cancer: Summary and Chartpack. Menlo Park, CA; USA Today, Kaiser Family Foundation, and Harvard School of Public Health; Washington, DC; 2006.
5. Mishan EJ. Evaluation of life and limb: a theoretical approach. J Polit Econ. 1971;79(4):687-705.
6. Shelling TC, Chase SB. The life you save may be your own. In: Shelling TC, Chase SB, eds. Problems in Public Expenditure Analysis. Washington, DC; Brookings Institution; 1968.
7. Aldy JE, Viscusi WK. Age differences in the value of statistical life: revealed preference evidence. Rev Environ Econ Policy. 2007;1(2):241-260.
8. Hausman JA, ed. Contingent Valuation: A Critical Assessment. Amsterdam, the Netherlands; Elsevier; 1993.
9. Arrow K, Solow R, Portney P, Leamer E, Radner R, Schuman H. Report of the NOAA Panel of Contingent Valuation. Federal Register. 1993;58(10):4602-4614.
10. American Cancer Society. American Cancer Society: Cancer Facts and Figures. Atlanta, GA; American Cancer Society; 2008.
11. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol. 2008;26(28):4617-4625.
12. Dooms CA, Lievens YN, Vansteenkiste JF. Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer. Eur Respir J. 2006;27(5):895-901.